Rite Aid Corporation RAD reported second-quarter earnings of 12 cents per share on Thursday, beating the analyst consensus estimate of 7 cents by 71.43%.
The company reported quarterly sales of $5.366 billion, missing the analyst consensus estimate of $5.41 billion by 0.81%.
Rite Aid narrowed is fiscal 2020 EPS guidance from a range of a loss of 14-72 cents to a range of zero to positive 56 cents. The Street is estimating a 2-cent adjusted EPS loss for 2020.
The company reaffirmed its 2020 sales guidance at a range of $21.5 billion-$21.9 billion versus a $21.61-billion estimate.
“In talking with many associates during my first 45 days, we know there is important work in front of us, and we are acting with urgency to finalize a strategic plan that positions our company to meet its full potential,” CEO Heyward Donigan said in a statement.
"As we continue these efforts, I'd like to thank our Rite Aid team for their hard work during the second-quarter. Our adjusted EBITDA results exceeded our plan driven by prescription count growth and strong expense control. This gives us important momentum for our future, and I look forward to working closely with our team to deliver a solid finish to our fiscal year and position Rite Aid as an innovative leader in our industry."
Rite Aid shares were trading up 9.88% at $8.45 in Thursday’s premarket session. The stock has a 52-week high of $27.20 and a 52-week low of $5.04.
Related Links:
VF Corporation Shares 2024 Guidance Plans
Photo by Joe Mabel via Wikimedia.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
